BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

723 related articles for article (PubMed ID: 31395338)

  • 1. Silencing of lemur tyrosine kinase 2 restricts the proliferation and invasion of hepatocellular carcinoma through modulation of GSK-3β/Wnt/β-catenin signaling.
    Zhao G; Song Y; Dong L; Shi H; Li H; Yang L; Wang J
    Biochem Biophys Res Commun; 2019 Oct; 517(4):722-728. PubMed ID: 31395338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lemur tyrosine kinase 2 silencing inhibits the proliferation of gastric cancer cells by regulating GSK-3β phosphorylation and β-catenin nuclear translocation.
    Han X; Wang DZ; Yuan M; Bai WJ
    Bioengineered; 2022 Mar; 13(3):6231-6243. PubMed ID: 34719320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ATDC promotes the growth and invasion of hepatocellular carcinoma cells by modulating GSK-3β/Wnt/β-catenin signalling.
    Li W; Xue H; Li Y; Li P; Ma F; Liu M; Kong S
    Clin Exp Pharmacol Physiol; 2019 Sep; 46(9):845-853. PubMed ID: 31168819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meningioma-associated protein 30 accelerates the proliferation and invasion of hepatocellular carcinoma by modulating Wnt/GSK-3β/β-catenin signaling.
    Zhang Y; Li H; Wang J; Geng X; Hai J
    J Bioenerg Biomembr; 2021 Feb; 53(1):73-83. PubMed ID: 33405049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spindle and kinetochore-associated protein 2 facilitates the proliferation and invasion of hepatocellular carcinoma via the regulation of Wnt/β-catenin signaling.
    Jiang J; Xu B; Zheng Y; Guo X; Chen F
    Exp Cell Res; 2020 Oct; 395(1):112181. PubMed ID: 32682011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRIM66 confers tumorigenicity of hepatocellular carcinoma cells by regulating GSK-3β-dependent Wnt/β-catenin signaling.
    Fan W; Du F; Liu X
    Eur J Pharmacol; 2019 May; 850():109-117. PubMed ID: 30710548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of lemur tyrosine kinase-2 protects neurons from oxygen-glucose deprivation/reoxygenation-induced injury through reinforcement of Nrf2 signaling by modulating GSK-3β phosphorylation.
    Bao H; Gao M
    Biochem Biophys Res Commun; 2020 Jan; 521(4):964-970. PubMed ID: 31722791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleolar and spindle-associated protein 1 accelerates cellular proliferation and invasion in nasopharyngeal carcinoma by potentiating Wnt/β-catenin signaling via modulation of GSK-3β.
    Zhang L; Dang Y; Wang Y; Fan X
    J Bioenerg Biomembr; 2020 Dec; 52(6):441-451. PubMed ID: 33196964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zanthoxylum avicennae extract enhances GSK-3β to attenuate β-catenin via phosphatase 2A to block metastatic effects of HA22T cells and hepatocellular carcinoma xenografted nude mice.
    Wu HC; Lay IS; Shibu MA; Ho TJ; Cheng SM; Lin CH; Dung TD; Jeng LB; Viswanadha VP; Huang CY
    Environ Toxicol; 2017 Sep; 32(9):2133-2143. PubMed ID: 28548306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing DEK downregulates cervical cancer tumorigenesis and metastasis via the DEK/p-Ser9-GSK-3β/p-Tyr216-GSK-3β/β-catenin axis.
    Xu X; Zou L; Yao Q; Zhang Y; Gan L; Tang L
    Oncol Rep; 2017 Aug; 38(2):1035-1042. PubMed ID: 28627610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lectin BS-I inhibits cell migration and invasion via AKT/GSK-3β/β-catenin pathway in hepatocellular carcinoma.
    Jian Q; Yang Z; Shu J; Liu X; Zhang J; Li Z
    J Cell Mol Med; 2018 Jan; 22(1):315-329. PubMed ID: 28922551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metallothionein 1H (MT1H) functions as a tumor suppressor in hepatocellular carcinoma through regulating Wnt/β-catenin signaling pathway.
    Zheng Y; Jiang L; Hu Y; Xiao C; Xu N; Zhou J; Zhou X
    BMC Cancer; 2017 Feb; 17(1):161. PubMed ID: 28241806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NDRG1 promotes growth of hepatocellular carcinoma cells by directly interacting with GSK-3β and Nur77 to prevent β-catenin degradation.
    Lu WJ; Chua MS; Wei W; So SK
    Oncotarget; 2015 Oct; 6(30):29847-59. PubMed ID: 26359353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physical exercise suppresses hepatocellular carcinoma progression by alleviating hypoxia and attenuating cancer stemness through the Akt/GSK-3β/β-catenin pathway.
    Xiao CL; Zhong ZP; Lü C; Guo BJ; Chen JJ; Zhao T; Yin ZF; Li B
    J Integr Med; 2023 Mar; 21(2):184-193. PubMed ID: 36781361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD58 acts as a tumor promotor in hepatocellular carcinoma via activating the AKT/GSK-3β/β-catenin pathway.
    Wang C; Cao F; Cao J; Jiao Z; You Y; Xiong Y; Zhao W; Wang X
    J Transl Med; 2023 Aug; 21(1):539. PubMed ID: 37573318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erinacine Facilitates the Opening of the Mitochondrial Permeability Transition Pore Through the Inhibition of the PI3K/ Akt/GSK-3β Signaling Pathway in Human Hepatocellular Carcinoma.
    Zhou LJ; Mo YB; Bu X; Wang JJ; Bai J; Zhang JW; Cheng AB; Ma JH; Wang YW; Xie YX
    Cell Physiol Biochem; 2018; 50(3):851-867. PubMed ID: 30355923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SKA3 promotes glioblastoma proliferation and invasion by enhancing the activation of Wnt/β-catenin signaling via modulation of the Akt/GSK-3β axis.
    Li C; Yang J; Lei S; Wang W
    Brain Res; 2021 Aug; 1765():147500. PubMed ID: 33895155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-557 inhibits hepatocellular carcinoma progression through Wnt/β-catenin signaling pathway by targeting RAB10.
    Cheng X; Wu C; Xu H; Zou R; Li T; Ye S
    Aging (Albany NY); 2024 Feb; 16(4):3716-3733. PubMed ID: 38364252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA DGCR5 represses hepatocellular carcinoma progression by inactivating Wnt signaling pathway.
    Wang XL; Shi M; Xiang T; Bu YZ
    J Cell Biochem; 2019 Jan; 120(1):275-282. PubMed ID: 30230592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FAM134B induces tumorigenesis and epithelial-to-mesenchymal transition via Akt signaling in hepatocellular carcinoma.
    Zhang ZQ; Chen J; Huang WQ; Ning D; Liu QM; Wang C; Zhang L; Ren L; Chu L; Liang HF; Fan HN; Zhang BX; Chen XP
    Mol Oncol; 2019 Apr; 13(4):792-810. PubMed ID: 30556279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.